Atellica CI Analyzer Revolutionizes Diagnostic Testing at Mahajan Imaging & Labs

Atellica has introduced its new CI analyzer at Mahajan Imaging & Labs, significantly advancing diagnostic testing. The technology provides swift, accurate results, reducing testing time and enhancing patient care. With its compact size and ability to assess over 200 parameters, the analyzer sets a new standard in medical diagnostics.

Atellica has launched its latest CI analyzer at Mahajan Imaging & Labs, marking a significant advancement in diagnostic testing. This state-of-the-art analyzer promises to make patient care both predictable and agile in today's fast-evolving healthcare landscape.

The Atellica CI analyzer's rapid, accurate output offers results in mere minutes. Dr. Harsh Mahajan, founder and Chief Radiologist, highlighted the critical role of this analyzer in clinical decision-making for various medical conditions. 'Being the first to implement the Atellica CI Analyzer is a significant milestone for us,' stated Dr. Mahajan. 'This technology enhances our capabilities in pathology and integrated diagnostics.'

Experts assert that the analyzer greatly improves patient comfort through its swift, precise results. It's a compact technological marvel capable of analyzing over 200 parameters across 20 disease states. Notably, its microvolume technology is particularly advantageous for pediatric and critical cases. With an ability to process key tests in just 14 minutes—far quicker than the conventional 22 to 40 minutes—it sets a new benchmark in rapid diagnostics.

Ranabir Sinha, Head of Diagnostics - Zone India, Siemens Healthineers, emphasized the shared vision of leveraging advanced technology to augment healthcare outcomes. Dr. Shelly Mahajan, Lab Director, stated, 'We have rigorously validated the analyzer over five months. It allows us to enable predictive care, secure data, and ensure quick Turn Around Time (TAT), all while reaching environmental goals. This innovative analyzer streamlines workflow and delivers precise diagnostics, ensuring Mahajan Imaging & Labs remains at the forefront of diagnostic innovation.'

The analyzer's approval by the U.S. Food and Drug Administration (FDA) reaffirms its adherence to the highest international standards for safety, effectiveness, and reliability, ensuring Mahajan Imaging & Labs continues to provide unparalleled patient care.